West Paces Advisors Inc. Immuno Precise Antibodies Ltd. Transaction History
West Paces Advisors Inc.
- $383 Billion
- Q2 2024
A detailed history of West Paces Advisors Inc. transactions in Immuno Precise Antibodies Ltd. stock. As of the latest transaction made, West Paces Advisors Inc. holds 1,665 shares of IPA stock, worth $949. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,665
Previous 1,665
-0.0%
Holding current value
$949
Previous $2.53 Million
33.54%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding IPA
# of Institutions
22Shares Held
1.66MCall Options Held
14.1KPut Options Held
6.9K-
Ingalls & Snyder LLC New York, NY1.3MShares$738,4010.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny63.9KShares$36,4280.0% of portfolio
-
Bank Of Montreal Toronto, A655.9KShares$31,8380.0% of portfolio
-
Northern Trust Corp Chicago, IL50.7KShares$28,9160.0% of portfolio
-
Cibc World Market Inc. Toronto, A641.2KShares$23,4830.0% of portfolio
About ImmunoPrecise Antibodies Ltd.
- Ticker IPA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,836,700
- Market Cap $14.2M
- Description
- ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...